Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP586196.RAsrLKIxA3erG53TYtWMG6LgKrwyMuBilm9Q5TauNLo_Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP586196.RAsrLKIxA3erG53TYtWMG6LgKrwyMuBilm9Q5TauNLo_Q130_assertion type Assertion NP586196.RAsrLKIxA3erG53TYtWMG6LgKrwyMuBilm9Q5TauNLo_Q130_head.
- NP586196.RAsrLKIxA3erG53TYtWMG6LgKrwyMuBilm9Q5TauNLo_Q130_assertion description "[For women, subjects featuring the CYP1A1*2C G/G genotype and the XRCC3 Thr/Thr genotype faced a 3.1-fold greater risk (95% CI = 1.3-7.0) of colorectal cancer when compared to those featuring the CYP1A1*2C A allele and the XRCC3 Met allele.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP586196.RAsrLKIxA3erG53TYtWMG6LgKrwyMuBilm9Q5TauNLo_Q130_provenance.
- NP586196.RAsrLKIxA3erG53TYtWMG6LgKrwyMuBilm9Q5TauNLo_Q130_assertion evidence source_evidence_literature NP586196.RAsrLKIxA3erG53TYtWMG6LgKrwyMuBilm9Q5TauNLo_Q130_provenance.
- NP586196.RAsrLKIxA3erG53TYtWMG6LgKrwyMuBilm9Q5TauNLo_Q130_assertion SIO_000772 17191090 NP586196.RAsrLKIxA3erG53TYtWMG6LgKrwyMuBilm9Q5TauNLo_Q130_provenance.
- NP586196.RAsrLKIxA3erG53TYtWMG6LgKrwyMuBilm9Q5TauNLo_Q130_assertion wasDerivedFrom befree-2016 NP586196.RAsrLKIxA3erG53TYtWMG6LgKrwyMuBilm9Q5TauNLo_Q130_provenance.
- NP586196.RAsrLKIxA3erG53TYtWMG6LgKrwyMuBilm9Q5TauNLo_Q130_assertion wasGeneratedBy ECO_0000203 NP586196.RAsrLKIxA3erG53TYtWMG6LgKrwyMuBilm9Q5TauNLo_Q130_provenance.